Amyloid Precursor Protein Processing and Alzheimer’s Disease
Kunal Joon*
University of NIIMS, Uttar Pradesh, India
*Corresponding Author: Kunal Joon, University of NIIMS, Uttar Pradesh, India.
Received:
May 24, 2024; Published: June 01, 2024
Abstract
Alzheimer’s disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms. Accumulation of cerebral amyloid-beta peptide (Abeta) is essential for developing synaptic and cognitive deficits in Alzheimer’s disease.
Keywords: Neurodegeneration; Dementia; BACE1; α-Secretase; γ-Secretase; Aging
References
- A Alzheimer., et al. “An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"”. Clinical Anatomy6 (1995): 429-431.
- Olav M Andersen., et al. “Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein”. Proceedings of the National Academy of Sciences of the United States of America38 (2005): 13461-13466.
- K Ando., et al. “Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid”. Journal of Biological Chemistry43 (2001): 40353-40361.
- Masashi Asai., et al. “Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase”. Biochemical and Biophysical Research Communications1 (2003): 231-235.
- James Ashley., et al. “Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint”. Journal of Neuroscience25 (2005): 5943-5955.
- Dimitrios Avramopoulos. “Genetics of Alzheimer's disease: recent advances”. Genome Medicine 3 (2009): 34.
- D M Barten., et al. “Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor”. Journal of Pharmacology and Experimental Therapeutics2 (2005): 635-643.
Citation
Copyright